![](https://cdn.rttnews.com/images/v4/RTTNews-logo-512x512.png)
NRx Pharma, HOPE Therapeutics Align With FDA On Pediatric Study Plan For NRX-100
NRx Pharmaceuticals, Inc. (NRXP), Monday announced that along with HOPE Therapeutics, Inc., the company would align with the U.S. Food and Drug Administration on an initial Pediatric Study Plan for NRX-100 for the treatment of suicidal depression in …